P1.213. Pushing Toward Routine POD 5 Discharge After RAMIE Within a Mature ERAS Environment May Safely Reduce Length of Stay

Clicks: 21
ID: 326211
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #158 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications Background ERAS pathways have shortened hospital stay after esophagectomy, yet discharge timing remains variable, particularly after robotic approaches. Early discharge (POD 5–6) has been shown to be feasible and safe in selected patients, but evidence specific to robotic-assisted minimally invasive esophagectomy (RAMIE) is limited. Observing progressively earlier discharge among uncomplicated patients, we revised our target discharge from POD 7 to POD 5. This study evaluates the safety and feasibility of a POD 5 discharge protocol compared with a prior POD 7 pathway in a high-performance center. Methods Consecutive patients undergoing RAMIE were analyzed before and after implementation of a postoperative day five discharge pathway (ERAS POD5). Outcomes included length of hospital stay (LOS) and 30-day readmission. Multivariate regression adjusted for clinical covariates. Results A total of 343 patients were included (POD7: n=221; POD5: n=122). Median LOS was shorter following POD5 pathway implementation (6 days [IQR 5–7] vs 8 days [IQR 7–11]; p<0.001). Unadjusted linear regression showed an apparent association with a shorter LOS (β = −3.21 days; 95% CI −5.34 to −1.08; p=0.003; R2=0.050). The association remained significant after multivariate adjustment (β = −3.26 days; 95% CI −5.62 to 0.90; p=0.007; R2=0.030). Thirty-day readmission rates were similar between groups (ERAS POD7: 12.4% vs ERAS POD5: 12.0%). ERAS POD5 discharge was not associated with increased readmission risk in unadjusted (OR 0.97, 95% CI 0.50–1.90) or adjusted analyses (adjusted OR 1.15, 95% CI 0.39–3.44). No increase in severe (Clavien–Dindo ≥III) readmission-related complications was observed. Conclusion Implementation of a POD 5 discharge pathway was associated with a safe reduction of hospitalization within a mature ERAS environment.
Reference Key
openalex_W7203970121 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Adam Zeyara, Marc van Det, Henk-Jan Mantel, Ewout van Kouwenhoven
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.361
URL
https://doi.org/10.1093/dote/doag077.361
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.